ADCT stock news
This page provides real-time market news, earnings updates, and company announcements related to ADC Therapeutics SA (ADCT).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-12 12:38 EST
Agree Realty’s Fortress Portfolio Presents an Undervalued Defensive Advantage and Reliable Monthly Dividends for Long-Term Investors
101 finance2026-04-02 16:15:49
Tempus AI Shares Rise After ALERT Trial Results Are Revealed
101 finance2026-04-02 19:03:49
OS Therapies Completes $5.25M Registered Direct Offering Primarily with Pre-Existing High-Net-Worth Investors
Finviz2026-04-02 21:18:49
Immunome’s CEO purchases shares during a 250% surge—while the CSO offloads at the top, raising doubts among savvy investors
101 finance2026-04-04 17:48:47
ArriVent BioPharma: Upcoming 2026 Trial Results May Trigger Significant Revaluation as Binary Catalyst Approaches
101 finance2026-04-05 03:12:42
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Finviz2026-04-07 12:03:44
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
Finviz2026-04-07 12:06:43
Pfizer’s 6.74% Dividend Yield Encounters Patent Expirations, Challenging Value Investors Amid Narrow Moat
101 finance2026-04-07 14:18:53
Gilead’s $415 Million ADC Option: An In-Depth Look at the Tubulis Agreement
101 finance2026-04-07 14:27:53
OS Therapies Appoints Craig Eagle, MD as Strategic Advisor
Finviz2026-04-08 15:39:53
Gilead’s $5 Billion ADC Investment Depends on TUB-040’s 59% ORR Demonstrating Market Potential
101 finance2026-04-08 17:30:49
How Pfizer's Cancer Treatment Lineup Is Evolving Ahead of First Quarter Earnings
101 finance2026-04-08 17:39:35
Institutional investors support Sidewinder’s dual-targeting ADC platform as the ADC industry approaches a new phase of innovation
101 finance2026-04-08 17:57:41
Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference
Finviz2026-04-08 20:09:50
C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)
Finviz2026-04-09 11:03:39
Akari Therapeutics Participates in Virtual Investor "What This Means" Interview Discussing Strategic Partnership with WuXi XDC
Finviz2026-04-09 12:54:48
Tempus AI's Clinical Validation and Pharmaceutical Collaborations Boost Trust in Precision Medicine
101 finance2026-04-10 01:48:51
Lantern Pharma’s withZeta.ai Faces April 9th Crucible: Can Its Rare Cancer AI Platform Prove Commercial Viability?
101 finance2026-04-10 12:45:54
Gilead Drops 2% but Leads Trading Activity as $5 Billion Tubulis Acquisition Drives $620 Million in Volume
101 finance2026-04-10 22:24:41
Pfizer's Recovery Play: Is the Market Underpricing Pricing Pressure and COVID Collapse?
101 finance2026-04-11 07:00:57
Pfizer's Lorbrena Redefines ALK-Positive Lung Cancer Care, Expands Total Addressable Market
101 finance2026-04-12 00:30:49
AbbVie Showcases Late-Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE) in Platinum-Sensitive Ovarian Cancer (PSOC) at SGO 2026
Finviz2026-04-12 11:18:39
GSK's High-Risk Oncology Bet: Can Next-Gen ADCs and Myeloid Engagers Deliver £40B in 6 Years?
101 finance2026-04-12 14:30:53
GSK’s Oncology Pipeline Race Against 2027 HIV Patent Cliff
101 finance2026-04-12 15:12:42
ArriVent BioPharma: Upcoming 2026 Trial Results May Trigger Significant Revaluation as Binary Catalyst Approaches
101 finance2026-04-05 03:12:42
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Finviz2026-04-07 12:03:44
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
Finviz2026-04-07 12:06:43
Pfizer’s 6.74% Dividend Yield Encounters Patent Expirations, Challenging Value Investors Amid Narrow Moat
101 finance2026-04-07 14:18:53
Gilead’s $415 Million ADC Option: An In-Depth Look at the Tubulis Agreement
101 finance2026-04-07 14:27:53
OS Therapies Appoints Craig Eagle, MD as Strategic Advisor
Finviz2026-04-08 15:39:53
Gilead’s $5 Billion ADC Investment Depends on TUB-040’s 59% ORR Demonstrating Market Potential
101 finance2026-04-08 17:30:49
How Pfizer's Cancer Treatment Lineup Is Evolving Ahead of First Quarter Earnings
101 finance2026-04-08 17:39:35
Institutional investors support Sidewinder’s dual-targeting ADC platform as the ADC industry approaches a new phase of innovation
101 finance2026-04-08 17:57:41
Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference
Finviz2026-04-08 20:09:50
C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)
Finviz2026-04-09 11:03:39
Akari Therapeutics Participates in Virtual Investor "What This Means" Interview Discussing Strategic Partnership with WuXi XDC
Finviz2026-04-09 12:54:48
Tempus AI's Clinical Validation and Pharmaceutical Collaborations Boost Trust in Precision Medicine
101 finance2026-04-10 01:48:51
Lantern Pharma’s withZeta.ai Faces April 9th Crucible: Can Its Rare Cancer AI Platform Prove Commercial Viability?
101 finance2026-04-10 12:45:54
Gilead Drops 2% but Leads Trading Activity as $5 Billion Tubulis Acquisition Drives $620 Million in Volume
101 finance2026-04-10 22:24:41
Pfizer's Recovery Play: Is the Market Underpricing Pricing Pressure and COVID Collapse?
101 finance2026-04-11 07:00:57
Pfizer's Lorbrena Redefines ALK-Positive Lung Cancer Care, Expands Total Addressable Market
101 finance2026-04-12 00:30:49
AbbVie Showcases Late-Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE) in Platinum-Sensitive Ovarian Cancer (PSOC) at SGO 2026
Finviz2026-04-12 11:18:39
GSK's High-Risk Oncology Bet: Can Next-Gen ADCs and Myeloid Engagers Deliver £40B in 6 Years?
101 finance2026-04-12 14:30:53
GSK’s Oncology Pipeline Race Against 2027 HIV Patent Cliff
101 finance2026-04-12 15:12:42
ADCT stock chart
ADCT stock detailsADCT stock price change
On the last trading day, ADCT stock closed at 3.74 USD, with a price change of -0.53% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more